Multicenter analysis of clinical characteristics and outcomes in patients with COVID-19 who develop liver injury

Affiliations

• ¹ CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China. Electronic address: qixiaolong@vip.163.com.
• ² CHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China.
• ³ CHESS-COVID-19 Group, Ankang Central Hospital, Ankang, China.
• ⁴ CHESS-COVID-19 Group, The Sixth People's Hospital of Shenyang, Shenyang, China.
• ⁵ CHESS-COVID-19 Group, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
• ⁶ CHESS-COVID-19 Group, Zhejiang University Lishui Hospital & Lishui Central Hospital, Lishui, China.
• ⁷ Department of Respiratory and Critical Care Medicine, The First Hospital of Lanzhou University, Lanzhou, China.
• ⁸ Department of Respiratory Medicine, The People's Hospital of Baoding, Baoding, China.
• ⁹ Department of Respiratory Medicine, The People's Hospital of LinXia Hui Prefecture, Linxia, China.
• ¹⁰ CHESS-COVID-19 Group, Xingtai People's Hospital, Xingtai, China.
• ¹¹ Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
• ¹² The First Hospital of Lanzhou University, Lanzhou, China.
• ¹³ Department of Infectious Diseases and Critical Care Medicine, The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China.
• ¹⁴ Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China. Electronic address: dongjh_btch@163.com.